Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 12 studies | 21% ± 7% | |
lung | 8 studies | 25% ± 9% | |
pancreas | 4 studies | 36% ± 11% | |
eye | 4 studies | 22% ± 8% | |
brain | 4 studies | 29% ± 7% | |
kidney | 3 studies | 18% ± 0% | |
placenta | 3 studies | 18% ± 4% | |
intestine | 3 studies | 24% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 10044.81 | 1445 / 1445 | 100% | 200.91 | 183 / 183 |
ovary | 100% | 7195.52 | 180 / 180 | 100% | 168.32 | 430 / 430 |
lung | 100% | 8996.26 | 578 / 578 | 100% | 261.30 | 1154 / 1155 |
skin | 100% | 15239.97 | 1809 / 1809 | 100% | 195.46 | 471 / 472 |
uterus | 100% | 9183.45 | 170 / 170 | 100% | 243.52 | 458 / 459 |
breast | 100% | 8077.61 | 459 / 459 | 100% | 192.26 | 1115 / 1118 |
stomach | 100% | 7186.84 | 359 / 359 | 100% | 129.96 | 285 / 286 |
brain | 99% | 7692.24 | 2627 / 2642 | 100% | 170.13 | 705 / 705 |
thymus | 100% | 8145.59 | 652 / 653 | 100% | 118.93 | 602 / 605 |
intestine | 100% | 9502.00 | 966 / 966 | 99% | 140.16 | 523 / 527 |
prostate | 100% | 7540.77 | 245 / 245 | 99% | 122.28 | 497 / 502 |
kidney | 100% | 7322.25 | 89 / 89 | 98% | 105.23 | 885 / 901 |
bladder | 100% | 9138.48 | 21 / 21 | 98% | 183.37 | 495 / 504 |
pancreas | 98% | 3911.12 | 322 / 328 | 99% | 129.20 | 176 / 178 |
liver | 98% | 5192.70 | 222 / 226 | 99% | 95.08 | 401 / 406 |
adrenal gland | 100% | 13538.90 | 258 / 258 | 91% | 88.85 | 209 / 230 |
adipose | 100% | 8725.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 170.87 | 29 / 29 |
muscle | 100% | 25730.55 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8458.61 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 327.72 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 66.08 | 1 / 1 |
blood vessel | 100% | 8578.07 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 9378.23 | 841 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 83.37 | 78 / 80 |
peripheral blood | 96% | 6369.44 | 888 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042176 | Biological process | regulation of protein catabolic process |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0000502 | Cellular component | proteasome complex |
GO_0034515 | Cellular component | proteasome storage granule |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0008540 | Cellular component | proteasome regulatory particle, base subcomplex |
GO_0005576 | Cellular component | extracellular region |
GO_0005838 | Cellular component | proteasome regulatory particle |
GO_0022624 | Cellular component | proteasome accessory complex |
GO_0016020 | Cellular component | membrane |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0005634 | Cellular component | nucleus |
GO_0030234 | Molecular function | enzyme regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PSMD2 |
Protein name | 26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Protein 55.11) (Tumor necrosis factor type 1 receptor-associated protein 2) Proteasome 26S subunit ubiquitin receptor, non-ATPase 2 |
Synonyms | TRAP2 |
Description | FUNCTION: Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. .; FUNCTION: Binds to the intracellular domain of tumor necrosis factor type 1 receptor. The binding domain of TRAP1 and TRAP2 resides outside the death domain of TNFR1. FUNCTION: Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. . |
Accessions | ENST00000432855.1 F8WBS8 ENST00000433010.5 ENST00000445558.6 H7C1H2 ENST00000435761.5 [Q13200-2] Q13200 ENST00000417952.5 H7C2Q3 ENST00000310118.9 [Q13200-1] C9JPC0 ENST00000439383.5 [Q13200-3] |